← Back to Patent Explorer
US5120842A Expired / Lapsed US ⏱️ 0.0 years remaining

Silyl ethers of rapamycin

Assignee: Wyeth LLC
•
Filing: 1991-04-01
•
Granted: 1992-06-09
•
Expires: 2011-04-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the structure <IMAGE> wherein R1 is -SiR3R4R5; R2 is hydrogen or -SiR3R4R5; and R3, R4, and R5 are each, independently, alkyl, alkenyl, aralkyl, triphenylmethyl, or phenyl which by virtue of its immunosuppressive activity is useful in treating transplantation rejection, host vs. graft disease, autoimmune diseases and diseases of inflammation; by virtue of its antitumor activity is useful in treating solid tumors; and by virtue of its antifungal activity is useful in treating fungal infections. This invention also provides a method of using rapamycin 42-[O-[(1,1-dimethylethyl)-dimethylsilyl] ether for the preparation of 31-substituted rapamycin derivatives.

Inventors

  • 👤 Amedeo A. Failli
  • 👤 Robert J. Steffan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 08:58
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804; A; A61; A61P; A61P29/00; A61P31/00; A61P31/04; A61P31/10; A61P35/00; A61P37/00; A61P37/02; A61P37/06

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 60 words
A compound of the formula ##STR3## wherein R 1 is --SiR 3 R 4 R 5 ; R 2 is hydrogen or --SiR 3 R 4 R 5 ; and R 3 , R 4 , and R 5 are each, independently, alkyl of 1-8 carbon atoms, alkenyl of 1-8 carbon atoms, phenylalkyl of 7-10 carbon atoms, triphenylmethyl, or phenyl.
Claim 2
Dependent Claim 60 words
A compound of the formula ##STR3## wherein R 1 is --SiR 3 R 4 R 5 ; R 2 is hydrogen or --SiR 3 R 4 R 5 ; and R 3 , R 4 , and R 5 are each, independently, alkyl of 1-8 carbon atoms, alkenyl of 1-8 carbon atoms, phenylalkyl of 7-10 carbon atoms, triphenylmethyl, or phenyl.
Claim 3
Dependent Claim 11 words
A compound of claim 1 in which R 2 is hydrogen.
Claim 4
Dependent Claim 27 words
A compound of claim 1 in which R 2 is hydrogen and R 3 , R 4 , and R 5 are alkyl of 1-8 carbon atoms.
Claim 5
Dependent Claim 22 words
A compound of claim 1 in which R 3 , R 4 , and R 5 are alkyl of 1-8 carbon atoms.
Claim 6
Dependent Claim 9 words
A compound of claim 1 which is rapamycin 42-O-[(1,1-dimethylethyl)dimethylsilyl]ether.
Claim 7
Dependent Claim 9 words
A compound of claim 1 which is rapamycin 31,42-bis-O-[(1,1-dimethylethyl)dimethylsilyl]ether.
Claim 8
Independent Claim 58 words
A method of using rapamycin 42-O-[(1,1-dimethylethyl)-dimethylsilyl]ether for the preparation of a 31-acylated rapamycin which comprises reacting rapamycin 42-[O-[(1,1-dimethylethyl)-dimethylsilyl]ether with an acylating agent to give an intermediate in which the 31-alcohol of rapamycin has reacted with the acylating agent and the 42-position is protected as the 42-[O-[(1,1-dimethylethyl)dimethylsilyl]ether; and subsequent hydrolysis of the 42-silyl ether to provide the 31-acylated rapamycin.
Claim 9
Independent Claim 58 words
A method of using rapamycin 42-O-[(1,1-dimethylethyl)-dimethylsilyl]ether for the preparation of a 31-acylated rapamycin which comprises reacting rapamycin 42-[O-[(1,1-dimethylethyl)-dimethylsilyl]ether with an acylating agent to give an intermediate in which the 31-alcohol of rapamycin has reacted with the acylating agent and the 42-position is protected as the 42-[O-[(1,1-dimethylethyl)dimethylsilyl]ether; and subsequent hydrolysis of the 42-silyl ether to provide the 31-acylated rapamycin.
Claim 10
Dependent Claim 6 words
A compound which is rapamycin 42-[O-[(1,1-Dimethylethyl)dimethylsilyl]ether-31-acetate.
Claim 11
Dependent Claim 6 words
A compound which is rapamycin 42-[O-[(1,1-Dimethylethyl)dimethylsilyl]ether-31-acetate.
Claim 12
Dependent Claim 5 words
A compound which is rapamycin-31-acetate.
Claim 13
Dependent Claim 5 words
A compound which is rapamycin-31-acetate.

References Cited (Backward Citations)

US3929992A Cited
US3993749A Cited
US4885171A Cited
US4316885A Cited
US4401653A Cited
US4650803A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-06-09 1995-12-09 1996-06-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-06-09 1999-12-09 2000-06-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-06-09 2003-12-09 2004-06-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag